Clinical Trials
2 trialsNCT07624838 2026-06-03
Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Recruiting
NCT05481437 2026-04-13
A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
Takeda
Recruiting